Nociceptin and the nociceptin receptor in learning and memory

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 62, Issue , 2015, Pages 45-50

  Andero, Raül ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Fear; Hippocampus; Memory; Nociceptin; Oprl1

Indexed keywords

ACETYLCHOLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NOCICEPTIN; NOCICEPTIN RECEPTOR; NORADRENALIN; OPIATE PEPTIDE; OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; BRAIN DISEASE; HIPPOCAMPAL CA1 REGION; HUMAN; LEARNING DISORDER; MEMORY DISORDER; MOLECULAR MECHANICS; NEUROPATHOLOGY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; LEARNING; MEMORY; METABOLISM; PHYSIOLOGY; STRESS DISORDERS, POST-TRAUMATIC;

ANIMALS; HUMANS; LEARNING; MEMORY; OPIOID PEPTIDES; RECEPTORS, OPIOID; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84937977853     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.02.007     Document Type: Review

References (64)

1. Andero R., Heldt S.A., Ye K., Liu X., Armario A., Ressler K.J. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry 2011, 168:163-172.
2. Andero R., Brothers S.P., Jovanovic T., Chen Y.T., Salah-Uddin H., Cameron M., et al. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med 2013, 5. [188ra173].
3. Beckham J.C., Crawford A.L., Feldman M.E., Kirby A.C., Hertzberg M.A., Davidson J.R., et al. Chronic posttraumatic stress disorder and chronic pain in Vietnam combat veterans. J Psychosom Res 1997, 43:379-389.
4. Blake M.G., Krawczyk M.C., Baratti C.M., Boccia M.M. Neuropharmacology of memory consolidation and reconsolidation: insights on central cholinergic mechanisms. J Physiol Paris 2014, 108(4-6):286-291.
5. Bodnar R.J. Endogenous opiates and behavior: 2012. Peptides 2013, 50:55-95.
6. Bongsebandhu-phubhakdi S., Manabe T. The neuropeptide nociceptin is a synaptically released endogenous inhibitor of hippocampal long-term potentiation. J Neurosci 2007, 27:4850-4858.
7. Cavallini S., Marino S., Beani L., Bianchi C., Siniscalchi A. Nociceptin inhibition of acetylcholine efflux from different brain areas. Neuroreport 2003, 14:2167-2170.
8. Devine D.P., Reinscheid R.K., Monsma F.J., Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res 1996, 727:225-229.
9. Fornari R.V., Soares J.C., Ferreira T.L., Moreira K.M., Oliveira M.G. Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats. Behav Neurosci 2008, 122:98-106.
10. Gavioli E.C., Calo G. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. Pharmacol Ther 2013, 140:10-25.
11. Goda Y., Mutneja M. Memory mechanisms: the nociceptin connection. Curr Biol 1998, 8:R889-R891.
12. Goeldner C., Reiss D., Wichmann J., Meziane H., Kieffer B.L., Ouagazzal A.M. Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. J Neurosci 2008, 28:2190-2198.
13. Goeldner C., Reiss D., Wichmann J., Kieffer B.L., Ouagazzal A.M. Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms. Neurobiol Learn Mem 2009, 91:393-401.
14. Hawes B.E., Graziano M.P., Lambert D.G. Cellular actions of nociceptin: transduction mechanisms. Peptides 2000, 21:961-967.
15. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Adam G., et al. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur J Neurosci 2002, 15:911-922.
16. Hiramatsu M., Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur J Pharmacol 1999, 367:151-155.
17. Hiramatsu M., Miwa M., Hashimoto K., Kawai S., Nomura N. Nociceptin/orphanin FQ reverses mecamylamine-induced learning and memory impairment as well as decrease in hippocampal acetylcholine release in the rat. Brain Res 2008, 1195:96-103.
18. Hitti F.L., Siegelbaum S.A. The hippocampal CA2 region is essential for social memory. Nature 2014, 508:88-92.
19. Homberg J.R., Mul J.D., de Wit E., Cuppen E. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors. Neuroscience 2009, 163:308-315.
20. Hostetler E.D., Sanabria-Bohorquez S., Eng W., Joshi A.D., Patel S., Gibson R.E., et al. Evaluation of [(1)(8)F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human. Neuroimage 2013, 68:1-10.
21. Huang J., Young B., Pletcher M.T., Heilig M., Wahlestedt C. Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence. Addict Biol 2008, 13:88-94.
22. Kawahara Y., Hesselink M.B., van Scharrenburg G., Westerink B.H. Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala. Eur J Pharmacol 2004, 485:197-200.
23. Kimura Y., Fujita M., Hong J., Lohith T.G., Gladding R.L., Zoghbi S.S., et al. Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors. J Nucl Med 2011, 52:1638-1645.
24. Knox D., George S.A., Fitzpatrick C.J., Rabinak C.A., Maren S., Liberzon I. Single prolonged stress disrupts retention of extinguished fear in rats. Learn Mem 2012, 19:43-49.
25. Ko M.C., Woods J.H., Fantegrossi W.E., Galuska C.M., Wichmann J., Prinssen E.P. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology 2009, 34:2088-2096.
26. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci U S A 1999, 96:10444-10449.
27. Kuzmin A., Madjid N., Johansson B., Terenius L., Ogren S.O. The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis. Brain Res 2009, 1305:S7-S19. [Suppl.].
28. Liberzon I., Krstov M., Young E.A. Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 1997, 22:443-453.
29. Linz K., Christoph T., Tzschentke T.M., Koch T., Schiene K., Gautrois M., et al. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist. J Pharmacol Exp Ther 2014, 349:535-548.
30. Lohith T.G., Zoghbi S.S., Morse C.L., Araneta M.F., Barth V.N., Goebl N.A., et al. Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A. J Nucl Med 2012, 53:385-392.
31. Lohith T.G., Zoghbi S.S., Morse C.L., Araneta M.D., Barth V.N., Goebl N.A., et al. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans. Neuroimage 2014, 87:89-95.
32. Mallimo E.M., Kusnecov A.W. The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation. Front Cell Neurosci 2013, 7:173.
33. Mamiya T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res 1998, 783:236-240.
34. Mamiya T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites. Neuroreport 1999, 10:1171-1175.
35. Mamiya T., Yamada K., Miyamoto Y., Konig N., Watanabe Y., Noda Y., et al. Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl-D-aspartate receptors. Mol Psychiatry 2003, 8:752-765.
36. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 1998, 394:577-581.
37. Maren S., Quirk G.J. Neuronal signalling of fear memory. Nat Rev Neurosci 2004, 5:844-852.
38. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol 1997, 340:1-15.
39. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377:532-535.
40. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 1994, 341:33-38.
41. New D.C., Wong Y.H. The ORL1 receptor: molecular pharmacology and signalling mechanisms. Neurosignals 2002, 11:197-212.
42. Nicol B., Lambert D.G., Rowbotham D.J., Smart D., McKnight A.T. Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol 1996, 119(6):1081-1083.
43. Pedregal C., Joshi E.M., Toledo M.A., Lafuente C., Diaz N., Martinez-Grau M.A., et al. Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor. J Med Chem 2012, 55:4955-4967.
44. Pike V.W., Rash K.S., Chen Z., Pedregal C., Statnick M.A., Kimura Y., et al. Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography. J Med Chem 2011, 54:2687-2700.
45. Redrobe J.P., Calo G., Guerrini R., Regoli D., Quirion R. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. Br J Pharmacol 2000, 131:1379-1384.
46. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270:792-794.
47. Reiss D., Prinssen E.P., Wichmann J., Kieffer B.L., Ouagazzal A.M. The nociceptin orphanin FQ peptide receptor agonist, Ro64-6198, impairs recognition memory formation through interaction with glutamatergic but not cholinergic receptor antagonists. Neurobiol Learn Mem 2012, 98:254-260.
48. Roozendaal B., Lengvilas R., McGaugh J.L., Civelli O., Reinscheid R.K. Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation. Learn Mem 2007, 14:29-35.
49. Saito Y., Maruyama K., Saido T.C., Kawashima S. N23K, a gene transiently up-regulated during neural differentiation, encodes a precursor protein for a newly identified neuropeptide nociceptin. Biochem Biophys Res Commun 1995, 217:539-545.
50. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci 1997, 9:194-197.
51. Sandin J., Georgieva J., Silberring J., Terenius L. In vivo metabolism of nociceptin/orphanin FQ in rat hippocampus. Neuroreport 1999, 10:71-76.
52. Sandin J., Ogren S.O., Terenius L. Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Res 2004, 997:222-233.
53. Seal K.H., Shi Y., Cohen G., Cohen B.E., Maguen S., Krebs E.E., et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012, 307:940-947.
54. Sigurdsson T., Doyere V., Cain C.K., LeDoux J.E. Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharmacology 2007, 52:215-227.
55. Siniscalchi A., Rodi D., Beani L., Bianchi C. Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices. Br J Pharmacol 1999, 128:119-123.
56. Spangler S., Peterson E.E., Alhasani R., Planer W., McCall J., Stuber G.G., Kash T.T., Jhou M.R., Bruchas M.R. Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices. Society for Neuroscience meeting 2012, VV10 756.11.
57. Taverna F.A., Georgiou J., McDonald R.J., Hong N.S., Kraev A., Salter M.W., et al. Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiation. J Physiol 2005, 565:579-591.
58. Thomsen C., Valsborg J.S., Platou J., Martin J., Foged C., Johansen N.L., et al. [3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor. Naunyn Schmiedebergs Arch Pharmacol 2000, 362:538-545.
59. Uezu K., Sano A., Sei H., Toida K., Houtani T., Sugimoto T., et al. Enhanced hippocampal acetylcholine release in nociceptin-receptor knockout mice. Brain Res 2005, 1050:118-123.
60. Xuei X., Flury-Wetherill L., Almasy L., Bierut L., Tischfield J., Schuckit M., et al. Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence. Addict Biol 2008, 13:80-87.
61. Yu T.P., Fein J., Phan T., Evans C.J., Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 1997, 7:88-94.
62. Zhang H., Wang F., Kranzler H.R., Zhao H., Gelernter J. Profiling of childhood adversity-associated DNA methylation changes in alcoholic patients and healthy controls. PLoS One 2013, 8:e65648.
63. Zhang Y., Simpson-Durand C.D., Standifer K.M. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br J Pharmacol 2014, 172(2):571-582.
64. Zola-Morgan S.M., Squire L.R. The primate hippocampal formation: evidence for a time-limited role in memory storage. Science 1990, 250:288-290.